AGP Executive Report
Last update: 3 hours agoHealthcare & Biotech: NICE has recommended Henlius’ PD-1 inhibitor serplulimab (Hetronifly®) for routine NHS use in England and Wales for extensive-stage small cell lung cancer, supporting use with standard chemotherapy. Industrial Policy & Energy: France’s economy stayed flat in Q2 (0.0%), with exports rebounding on aeronautics and consumption improving, but the outlook remains pressured by external shocks and budget strain. Manufacturing & Supply Chains: A new Morocco plant from China’s Sanlian Forging will make precision-forged automotive parts and vehicle electrical/electronic equipment in Tangier, adding momentum to the country’s auto supply ecosystem. EV Market Signals: Europe’s BEV registrations jumped 51% year-on-year in July, lifting BEV share to 26% of the market, while plugin hybrids grew more slowly. Critical Minerals: A “mineral corridor” analysis argues the next industrial power game is won by processing and manufacturing ecosystems, not just mines—highlighting China’s dominance in refining and integration. Defense-Industrial Angle: Poland received five more F-35A jets, expanding its Air Force fleet under the Harpia procurement.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
